Leap Therapeutics, INC.
SEC CIK 1509745 · LPTX · last insider filing 2026-03-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mirabelli Christopher | Director · President, CEO & COB | filed 2017 - 2026 |
| Cavanaugh James H | Director | filed 2017 - 2026 |
| LI William | Director | filed 2017 - 2026 |
| Loscalzo Joseph | Director | filed 2017 - 2026 |
| Mashiach Nissim | Director | filed 2017 - 2026 |
| Dietz Thomas John | Director | filed 2017 - 2026 |
| Richard Christian M | Director | filed 2023 - 2026 |
| Martin Patricia A. | Director | filed 2023 - 2026 |
| Schilsky Richard | Director | filed 2022 - 2026 |
| Oei Khing Djien | Director | filed 2025 - 2026 |
| Onsi Douglas E | Director · CFO,Gen Counsel,Treas, Sec. | filed 2017 - 2025 |
| Mcevoy William Patrick III | Director · Chief Investment Officer | filed 2025 - 2025 |
| Bertagnolli Monica | Director | filed 2018 - 2022 |
| Littlechild John W | Director | filed 2017 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lawlor Augustine | Chief Operating Officer | filed 2017 - 2025 |
| O'Mahony John Mark | Chief Manufacturing Officer | filed 2020 - 2025 |
| Baum Jason | Chief Scientific Officer | filed 2023 - 2025 |
| Sirard Cynthia | Chief Medical Officer | filed 2020 - 2025 |
| Granfield Christine | VP, Head of Reg Affairs/Qual | filed 2020 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.